HOUSHANG SANAII: Open Payments
NPI 1558349837 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,325 in 12 payments from 9 companies in 2025. Trend: 2023 $295 · 2024 $689 · 2025 $1,325
Food & beverage: $1,325
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $410 |
| Calliditas Therapeutics US Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Amgen Inc. | 1 | $123 |
| Eisai Inc. | 1 | $122 |
| SCPHARMACEUTICALS INC. | 1 | $115 |
| Travere Therapeutics, Inc. | 1 | $114 |
| AstraZeneca Pharmaceuticals LP | 1 | $100 |
| Mallinckrodt Hospital Products Inc. | 1 | $91 |
Products named: Wegovy, TARPEYO, JYNARQUE, TAVNEOS, Leqembi, Ozempic, FUROSCIX, Filspari.
Industry payments across OH — which companies pay providers there.
